FLT3 and acute myeloid leukemia: Inhibition of autophagy could be a specific vulnerability in these cells but efficacy was reduced when combined with FLT3-targeted inhibitors suggesting the process could be specific to FLT3-ITD AML or associated with FLT3 signaling.71